Medicenna Therapeutics所有資訊

Medicenna Therapeutics | 15-12G：終止註冊

2024/05/14 16:35 (美東)

Medicenna Therapeutics | D：發行公告

2024/05/14 15:45 (美東)

Medicenna Therapeutics | EFFECT：其他

2024/05/14 06:11 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/05/13 14:34 (美東)

Medicenna Therapeutics | SC 13G：超過5%持股股東披露文件-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等

2024/05/10 17:54 (美東)

Medicenna Therapeutics | POS AM：修改註冊聲明表

2024/05/10 16:13 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/04/30 15:11 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/04/26 15:30 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/04/25 14:05 (美東)

Medicenna Therapeutics | AW：撤銷修改註冊聲明

2024/04/22 16:42 (美東)

Medicenna Therapeutics | F-10POS：其他

2024/04/16 17:06 (美東)

Medicenna Therapeutics | F-3/A：交易註冊聲明（修正）

2024/04/16 17:06 (美東)

Medicenna Therapeutics | S-8 POS：員工福利計劃證券登記(修正)

2024/04/16 17:06 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/04/10 13:52 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/04/09 14:10 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/04/04 14:01 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/03/06 11:03 (美東)

Medicenna Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Fahar Merchant(29.1%),Rosemina Merchant(29.1%)等

2024/02/21 20:32 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告（業績相關）

2024/02/14 07:31 (美東)

Medicenna Therapeutics | 6-K：外國發行人報告

2024/02/13 10:34 (美東)